Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Arrowhead Pharmaceuticals
Biotech
Arrowhead posts phase 3 data ahead of market clash with Ionis
Arrowhead has shown its hand ahead of a showdown with Ionis, publishing phase 3 data on a rare metabolic disease drug that is racing to regulators.
Nick Paul Taylor
Sep 3, 2024 9:27am
Arrowhead dips toes into obesity pond with 2 preclinical assets
Aug 14, 2024 3:50pm
Arrowhead axes one heart disease drug, goes all in on another
Jun 26, 2024 7:00am
Arrowhead RNAi med lowers triglycerides in phase 3
Jun 3, 2024 9:54am
Arrowhead's cholesterol drug hits the mark again in ph. 2 trial
May 28, 2024 9:13am
Arrowhead on target in lipid disorder as it pursues Ionis
Apr 8, 2024 9:37am